Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-25

Clinical Trial Update: A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of OnabotulinumtoxinA for upper facial wrinkles, including glabellar lines, with results posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Facial Rhytides, Glabellar Rhytides | Phase 3 | Status: COMPLETED | Results posted: 2017-07-25